Stem Cell Stocks Tick Higher After NIH Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in Adults

Go back to Stem Cell Stocks Tick Higher After NIH Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in Adults
AASTROM BIOSCIENCES (NASDAQ: ASTM) Delayed: 2.77 --0 (-0%)
Previous Close $2.77    52 Week High $7.00 
Open $0.94    52 Week Low $2.55 
Day High $2.77    P/E N/A 
Day Low $2.77    EPS $-23.68 
Volume 46,665       

Geron Corp (NASDAQ: GERN) Delayed: 1.53 +0.06 (4.08%)
Previous Close $1.47    52 Week High $5.30 
Open $1.46    52 Week Low $1.81 
Day High $1.55    P/E N/A 
Day Low $1.45    EPS $-0.35 
Volume 8,409,753       

STEMCELLS (NYSE: STEM) Delayed: 6.10 -0.24 (3.79%)
Previous Close $6.34    52 Week High $3.08 
Open $6.41    52 Week Low $0.21 
Day High $6.45    P/E N/A 
Day Low $6.03    EPS $-0.49 
Volume 91,522